Social Cognition Training in Individuals With Huntington's Disease
Launched by RUSH UNIVERSITY MEDICAL CENTER · Feb 11, 2025
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help people with Huntington's Disease improve their social skills through something called computerized social cognition training. Social cognition is about understanding how other people feel and think, which is important for interacting with them effectively. People with Huntington's Disease often struggle with these skills, which can affect their relationships and overall well-being. The researchers believe that this training can not only help those with Huntington's Disease but also make life easier for their caregivers, who often face significant challenges.
To participate in the trial, individuals with Huntington's Disease must be between 18 and 65 years old, diagnosed through genetic testing, and able to understand and read English. They should also be stable on their medications and have access to a computer or mobile device. Caregivers living with these individuals can also join if they meet similar age and language requirements. Participants will attend in-person visits over a few months to take part in the training and assessments. This study is a first step to see if the training is feasible and beneficial before moving on to a larger trial.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria for Individual with Huntington's Disease
- • Diagnosed with Huntington's Disease based on genetic testing
- • Must be between 18 and 65 years of age
- • Native English speaker who is literate in English
- • Stable psychotropic medication regimen for 4 weeks
- • Must have a score of "somewhat easily" on all items in the CPQ-12
- • MOCA \>18
- • Completed 12 years of schooling
- • Access to laptop or mobile device
- • Willingness to come in person 6-12 weeks after first visit
- • Inclusion Criteria for Caregiver of Individual with Huntington's Disease
- • Lives with patient
- • Must be between 18 and 65 years of age
- • Native English speaker who is literate in English
- • MOCA \>26
- • Willingness to come in person within 6-12 weeks after first visit
- • Exclusion Criteria for Individual with Huntington's Disease
- • Any known neurological condition (other than Huntington's Disease).
- • History of learning and/or intellectual disabilities
- • Currently actively involved in any other interventional trial (i.e. have begun the intervention) or within 4 weeks of completing the final assessments of an interventional trial.
- • Currently regularly completing a computerized cognitive training intervention.
- • Active suicidal ideation with some intent
- • Exclusion Criteria for Caregiver of Individual with Huntington's Disease
- • Inability to provide informed consent
- • Active suicidal ideation with some intent
About Rush University Medical Center
Rush University Medical Center is a leading academic medical institution located in Chicago, Illinois, dedicated to advancing healthcare through innovative research and clinical trials. As a sponsor of numerous clinical studies, Rush focuses on translating scientific discoveries into effective treatments and improving patient outcomes across a variety of medical disciplines. With a commitment to excellence in patient care, education, and research, Rush leverages its state-of-the-art facilities and a robust network of specialists to conduct comprehensive trials that adhere to the highest ethical and regulatory standards. Through collaboration with a diverse patient population, Rush aims to enhance the understanding of diseases and develop novel therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported